These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26988871)

  • 1. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
    Spyropoulos AC; Al-Badri A; Sherwood MW; Douketis JD
    J Thromb Haemost; 2016 May; 14(5):875-85. PubMed ID: 26988871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Shah S; Nayfeh T; Hasan B; Urtecho M; Firwana M; Saadi S; Abd-Rabu R; Nanaa A; Flynn DN; Rajjoub NS; Hazem W; Seisa MO; Hassett LC; Spyropoulos AC; Douketis JD; Murad MH
    Chest; 2023 May; 163(5):1245-1257. PubMed ID: 36462533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings.
    Nikolakopoulos I; Spyropoulos AC
    Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.
    Douketis JD; Spyropoulos AC
    JAMA; 2024 Sep; 332(10):825-834. PubMed ID: 39133476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.
    Douketis JD; Spyropoulos AC; Murad MH; Arcelus JI; Dager WE; Dunn AS; Fargo RA; Levy JH; Samama CM; Shah SH; Sherwood MW; Tafur AJ; Tang LV; Moores LK
    Chest; 2022 Nov; 162(5):e207-e243. PubMed ID: 35964704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Douketis JD; Spyropoulos AC; Spencer FA; Mayr M; Jaffer AK; Eckman MH; Dunn AS; Kunz R
    Chest; 2012 Feb; 141(2 Suppl):e326S-e350S. PubMed ID: 22315266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.
    Douketis JD; Spyropoulos AC; Murad MH; Arcelus JI; Dager WE; Dunn AS; Fargo RA; Levy JH; Samama CM; Shah SH; Sherwood MW; Tafur AJ; Tang LV; Moores LK
    Chest; 2022 Nov; 162(5):1127-1139. PubMed ID: 35964703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
    Siegal D; Yudin J; Kaatz S; Douketis JD; Lim W; Spyropoulos AC
    Circulation; 2012 Sep; 126(13):1630-9. PubMed ID: 22912386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of antithrombotic therapy: a case-based narrative review.
    Chen AT; Patel M; Douketis JD
    Intern Emerg Med; 2022 Jan; 17(1):25-35. PubMed ID: 34652572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding.
    Palareti G
    Semin Hematol; 2014 Apr; 51(2):102-11. PubMed ID: 24861794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.